These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 33361736)
41. TRB3 interacts with ERK and JNK and contributes to the proliferation, apoptosis, and migration of lung adenocarcinoma cells. Cao X; Fang X; Malik WS; He Y; Li X; Xie M; Sun W; Xu Y; Liu X J Cell Physiol; 2020 Jan; 235(1):538-547. PubMed ID: 31256425 [TBL] [Abstract][Full Text] [Related]
42. Molecular and Immune Characteristics for Lung Adenocarcinoma Patients With ERLIN2 Overexpression. Liu Y; Xie P; Jiang D; Liu J; Zhang J; Bian T; Shi J Front Immunol; 2020; 11():568440. PubMed ID: 33424830 [TBL] [Abstract][Full Text] [Related]
43. Bioinformatics Analysis and Experimental Study of Exonuclease 1 Gene in Lung Adenocarcinoma. Wang S; Cai W; Li J; An W; Zheng H; Liao M Biochem Genet; 2022 Dec; 60(6):1934-1945. PubMed ID: 35169964 [TBL] [Abstract][Full Text] [Related]
44. Elevated Glutathione Peroxidase 2 Expression Promotes Cisplatin Resistance in Lung Adenocarcinoma. Du H; Chen B; Jiao NL; Liu YH; Sun SY; Zhang YW Oxid Med Cell Longev; 2020; 2020():7370157. PubMed ID: 32215178 [TBL] [Abstract][Full Text] [Related]
45. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models. Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990 [TBL] [Abstract][Full Text] [Related]
46. Genome‑wide investigation of the clinical significance and prospective molecular mechanisms of kinesin family member genes in patients with lung adenocarcinoma. Zhang L; Zhu G; Wang X; Liao X; Huang R; Huang C; Huang P; Zhang J; Wang P Oncol Rep; 2019 Sep; 42(3):1017-1034. PubMed ID: 31322267 [TBL] [Abstract][Full Text] [Related]
47. Genome-wide analysis of the hypoxia-related DNA methylation-driven genes in lung adenocarcinoma progression. Li H; Tong L; Tao H; Liu Z Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32031203 [TBL] [Abstract][Full Text] [Related]
48. MiR-340-3p-HUS1 axis suppresses proliferation and migration in lung adenocarcinoma cells. Ren K; Yu Y; Wang X; Liu H; Zhao J Life Sci; 2021 Jun; 274():119330. PubMed ID: 33711383 [TBL] [Abstract][Full Text] [Related]
49. LDH-A promotes malignant behavior via activation of epithelial-to-mesenchymal transition in lung adenocarcinoma. Hou XM; Yuan SQ; Zhao D; Liu XJ; Wu XA Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30509961 [TBL] [Abstract][Full Text] [Related]
50. LncRNA GMDS-AS1 inhibits lung adenocarcinoma development by regulating miR-96-5p/CYLD signaling. Zhao M; Xin XF; Zhang JY; Dai W; Lv TF; Song Y Cancer Med; 2020 Feb; 9(3):1196-1208. PubMed ID: 31860169 [TBL] [Abstract][Full Text] [Related]
51. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma. Li J; Liu X; Cui Z; Han G Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582 [TBL] [Abstract][Full Text] [Related]
52. HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling. Jiang N; Zou C; Zhu Y; Luo Y; Chen L; Lei Y; Tang K; Sun Y; Zhang W; Li S; He Q; Zhou J; Chen Y; Luo J; Jiang W; Ke Z Theranostics; 2020; 10(6):2553-2570. PubMed ID: 32194819 [No Abstract] [Full Text] [Related]
53. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma. Xu XL; Gong Y; Zhao DP Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913 [TBL] [Abstract][Full Text] [Related]
54. Establishment of a Gene Signature to Predict Prognosis for Patients with Lung Adenocarcinoma. Li Z; Qi F; Li F Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187219 [TBL] [Abstract][Full Text] [Related]
55. Knockdown of microsomal glutathione S-transferase 1 inhibits lung adenocarcinoma cell proliferation and induces apoptosis. Zeng B; Ge C; Li R; Zhang Z; Fu Q; Li Z; Lin Z; Liu L; Xue Y; Xu Y; He J; Guo H; Li C; Huang W; Song X; Huang Y Biomed Pharmacother; 2020 Jan; 121():109562. PubMed ID: 31707341 [TBL] [Abstract][Full Text] [Related]
56. Downregulated miR-144-3p contributes to progression of lung adenocarcinoma through elevating the expression of EZH2. Liu C; Yang Z; Deng Z; Zhou Y; Gong Q; Zhao R; Chen T Cancer Med; 2018 Nov; 7(11):5554-5566. PubMed ID: 30280514 [TBL] [Abstract][Full Text] [Related]
57. Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patients. Schlensog M; Magnus L; Heide T; Eschenbruch J; Steib F; Tator M; Kloten V; Rose M; Noetzel E; Gaisa NT; Knüchel R; Dahl E Epigenetics; 2018; 13(3):214-227. PubMed ID: 27623992 [TBL] [Abstract][Full Text] [Related]
58. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level. Wang W; Ren S; Wang Z; Zhang C; Huang J Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070 [TBL] [Abstract][Full Text] [Related]
59. Pseudogene CHIAP2 inhibits proliferation and invasion of lung adenocarcinoma cells by means of the WNT pathway. Shang J; Wang Z; Chen W; Yang Z; Zheng L; Wang S; Li S J Cell Physiol; 2019 Aug; 234(8):13735-13746. PubMed ID: 30623445 [TBL] [Abstract][Full Text] [Related]
60. PRMT6 serves an oncogenic role in lung adenocarcinoma via regulating p18. Tang J; Meng Q; Shi R; Xu Y Mol Med Rep; 2020 Oct; 22(4):3161-3172. PubMed ID: 32945431 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]